Literature DB >> 27030929

Update: Exertional rhabdomyolysis, active component, U.S. Army, Navy, Air Force, and Marine Corps, 2011-2015.

.   

Abstract

Among active component members of the U.S. Army, Navy, Air Force, and Marine Corps in 2015, there were 456 incident episodes of rhabdomyolysis likely due to physical exertion or heat stress ("exertional rhabdomyolysis"). Annual rates of incident diagnoses of exertional rhabdomyolysis increased 17% between 2014 and 2015. In 2015, the highest incidence rates occurred in service members who were male; younger than 20 years of age; black, non-Hispanic; members of the Marine Corps and Army; recruit trainees; and in combat-specific occupations. Most cases of exertional rhabdomyolysis were diagnosed at installations that support basic combat/recruit training or major ground combat units of the Army or Marine Corps. Medical care providers should consider exertional rhabdomyolysis in the differential diagnosis when service members (particularly recruits) present with muscular pain and swelling, limited range of motion, or the excretion of dark urine (e.g., myoglobinuria) after strenuous physical activity, particularly in hot, humid weather.

Entities:  

Mesh:

Year:  2016        PMID: 27030929

Source DB:  PubMed          Journal:  MSMR        ISSN: 2152-8217


  3 in total

1.  Impact of raising serum myoglobin on resuscitation of trauma patients with high injury severity score (ISS).

Authors:  Tarik Wasfie; Bradley DeLeu; Addison Roberts; Jennifer Hille; Tara Knisley; Jennifer McCullough; Raquel Yapchai; Kimberly R Barber; Brian Shapiro
Journal:  Surg Open Sci       Date:  2020-01-11

2.  Risk factors for exertional rhabdomyolysis with renal stress.

Authors:  Terje Apeland; Tore Danielsen; Eva M Staal; Anders Åsberg; Inga S Thorsen; Tom Ole Dalsrud; Stein Ørn
Journal:  BMJ Open Sport Exerc Med       Date:  2017-07-06

3.  Exertional Rhabdomyolysis after Military Training Paralleled by Systemic Microvascular Dysfunction and Plasma Cytokine Increase: A Case Report.

Authors:  Flavio Pereira; Roger de Moraes; Diogo Bavel; Andrea Rocha de Lorenzo; Eduardo Tibirica
Journal:  Arq Bras Cardiol       Date:  2019-09-02       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.